The Top 8 Market-Moving Healthcare Stories of 2017
Attempts to repeal and replace the Affordable Care Act dominated healthcare headlines in the first half of 2017, but there was plenty of other healthcare news that moved stocks higher and lower this year. For instance, advances in gene therapy pushed us closer toward personalized and precision medicine, the FDA's Scott Gottlieb orchestrated a restructuring that's accelerating drug development, and the nation's biggest e-commerce company flirted with getting into the drug business.
In today's episode of The Motley Fool's Industry Focus: Healthcare, analyst Kristine Harjes and healthcare stock-picker Todd Campbell highlight the biggest healthcare stories of 2017, including the launch of game-changing drugs from Biogen (NASDAQ: BIIB) and Gilead Sciences(NASDAQ: GILD), how we're trying to solve the opioid crisis, why Amazon.com (NASDAQ: AMZN) has Walgreens Boots Alliance (NASDAQ: WBA) and CVS Health (NYSE: CVS) scurrying, and more.
A full transcript follows the video.
Source: Fool.com
Amazon.com Inc. Aktie
Mit 166 Buy-Einschätzungen und nur 1 Sell-Einschätzungen ist Amazon.com Inc. einer der Lieblinge unserere Community.
Für Amazon.com Inc. sieht die Community ein Kursziel von 190 €, was eine erhebliche Steigerung um über 20% gegenüber dem aktuellen Kurs von 153.76 € bedeutet.
